drugset / Trial / NCT05052541

Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

NCT05052541

RandomizedCrossoverTriple-blindTreatment

Summary

The overall objectives of this study are to investigate the efficacy of extended cannabis treatment to reduce patient exposure to prescription opioids through its use 1) as a non-opioid analgesic treatment, and 2) as a therapy for reducing high-dose opioid use in patients with chronic spine pain.

Timeline

Start
2026-01
Primary completion
2027-06
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject CBD Unknown 50 mg/ml Oral
Subject Dronabinol Other / unclassified 5 mg/ml Oral

Indications